Neuronetics (STIM) Shares Outstanding (Weighted Average) (2016 - 2026)
Neuronetics has reported Shares Outstanding (Weighted Average) over the past 11 years, most recently at $2.0 million for Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 13.04% to $2.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2026, up 13.04% year-over-year, with the annual reading at $2.0 million for FY2025, 13.04% up from the prior year.
- Shares Outstanding (Weighted Average) was $2.0 million for Q1 2026 at Neuronetics, roughly flat from $2.0 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $63.8 million in Q2 2025 and troughed at $21000.0 in Q2 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $2.0 million (2025), against an average of $14.3 million.
- Year-over-year, Shares Outstanding (Weighted Average) plummeted 99.77% in 2023 and then soared 303876.19% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $26.9 million in 2022, then rose by 6.54% to $28.7 million in 2023, then plummeted by 93.98% to $1.7 million in 2024, then rose by 13.04% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
- Per Business Quant, the three most recent readings for STIM's Shares Outstanding (Weighted Average) are $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025).